UA College of Medicine Phoenix | 2013 Commencement
2013 Commencement UA College of Medicine – Phoenix Fifty University of Arizona College of Medicine -- Phoenix medical students were officially conferred with their medical degrees at ceremonies on May 8 in the third graduation for the downtown Phoenix medical school. Read more: http://phoenixmed.arizona.edu
Cancer Genomics: the future of personalized medicine
2012 Bioscience Leader of the Year, Robert Penny, MD, PhD shares the history of the Cancer Genome Atlas Project and a look forward at the future of personalized medicine.
Building a Medical School
A dream come true for downtown Phoenix; Building a new medical school For six local doctors, the creation of what is now one of the newest medical colleges in the nation seemed a distant dream. These seasoned professionals have invested many years, personal and professional commitment, expertise and downright tenacity, to make this campus and this college a reality. All contributed from their respective fields and their respective hospitals. All were teachers and saw the need for the development of the University of Arizona College of Medicine - Phoenix. Read more at: http://phoenixmed.arizona.edu
Jennifer Kehlet Barton, PhD, 2012 Bioscience Educator of the Year
Jennifer Kehlet Barton, Ph.D., Associate Vice President for Research and Professor, Biomedical Engineering at The University of Arizona was named the 2012 Michael A. Cusanovich Bioscience Educator of the Year by the Arizona Bioindustry Association. Dr. Barton was nominated by students, past and present with supporting nominations by her co-workers, and selected for this honor by an independent panel of judges from across the state of Arizona for her contributions to all aspects of bioscience education. They include her skill as a course instructor, her compassion and patience as a mentor and adviser to undergraduate and graduate students, her strategic leadership in creating a learning environment and career path for students via her development and leadership of the UA Biomedical Engineering Programs, her recent role as Assistant Director of the BIO5 Institute, and her participation with industry in a broad range of industry association and community groups.
Convergence and Personalized Medicine
Greg Yap is Senior Vice President and Lifecycle Leader for Advanced Staining Assays at Ventana Medical Systems. In this role, Greg is responsible for Ventana’s 450 million dollar cancer diagnostic testing business. Ventana’s tests are the market leaders and are used to help guide treatment for over 6 million cancer patients each year worldwide. Previously, Greg was Chief Operating Officer at Cellective Dx, a circulating tumor cell company, and held multiple senior operating roles at Affymetrix.
David S Alberts AZBio Pioneer
David S. Alberts, MD. Throughout his career, Dr. Alberts has focused on translational cancer prevention and treatment research. The emphasis of his laboratory-based and clinical research has been on the chemoprevention and treatment of such pervasive and potentially deadly diseases as cancers of the breast, colon, ovary, and skin. He has been the UA Cancer Center’s director since 2005. Under Dr. Alberts’ leadership the extensive research portfolio of The University of Arizona Cancer Center includes more than $60 million in annual research funding, including four large NCI interdisciplinary programs, and two Special Programs of Research Excellence, one in gastrointestinal cancers and one in lymphoma. Clinically, Dr. Alberts pioneered new treatments for advanced ovarian cancers, including in vitro tumor cell chemosensitivity testing for personalized medicine strategies, intraperitoneal chemotherapy , and maintenance chemotherapy. Presently, Dr. Alberts helps to coordinate Phase I and II and pharmacokinetic drug studies at The University of Arizona Cancer Center for molecularly-targeted chemopreventive agents. His laboratory research is concentrated on the evaluation of new surrogate endpoint biomarkers for cancer prevention trials with a special focus on precursor lesions for bladder, breast, colon, cervical, endometrial, ovarian, prostate, and skin cancers, using quantitative histopathology (i.e. karyometric) approaches. His NCI funded drug and diagnostics research has resulted in more than two dozen patents and the co-founding of five Arizona pharmaceutical and biotechnology companies.
Ground Broken for University of Arizona Cancer Center in Phoenix
Ground Broken for University of Arizona Cancer Center in Phoenix Ground was officially broken on the new University of Arizona Cancer Center (UACC) at St. Joseph's Hospital and Medical Center/Dignity Health outpatient facility in downtown Phoenix in February, 2013. Located on the Phoenix Biomedical Campus at 625 N. Sixth St., on the northwest corner of Fillmore and Seventh streets, the center is expected to be open in 2015. Follow the project's construction progress at www.phoenixcancercenter.org
Bio Ag: Foresight and Integrating Vision Systems
The University of Arizona Controlled Environment Agriculture Center Controlled Environment Agriculture (CEA) is the production of plants and their products, such as vegetables and flowers, inside structures such as greenhouses. By using CEA, we can produce high value crops at maximum productivity in an efficient and environmentally friendly way. The University of Arizona's Controlled Environment Agriculture Center (CEAC) supports education, research and outreach as part of the Department of Agricultural & Biosystems Engineering and the School of Plant Sciences - both programs of the College of Agriculture and Life Sciences. CEAC also offers an innovation platform for plant physiology, sensor technology and applied computer technology.